Using glucagon receptor antagonism to evaluate the physiological effects of extrapancreatic glucagon in totally pancreatectomised individuals: a randomised controlled trial.

Diabetologia · 2025 · PMC12594659 · PMID 40968190

Europe PMC DOI

hedged sentence

0.0790

closest p · 1.6× alpha

0.0790

boldest claim

The sentences

did not reach statistical significancep =0.079so close (0.05 < p ≤ 0.1)

In the control group, mean fasting concentrations of glucagon were fourfold higher on the LY2409021 day than on the placebo day but the difference did not reach statistical significance (7.4 [3.1] vs 1.9 [0.4] pmol/l, p =0.079).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.